Video

SWIFT PRIME Shows Strong Results for Endovascular Therapy Part 2

Author(s):

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

Jeffrey Saver, MD, FAHA, FAAN, from the Geffen School of Medicine at UCLA discussed the results of the study and the impact of the development of the therapy on the treatment of stroke at the International Stroke Conference in Nashville.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.